MECHANISMS OF TROPHIC MOLECULES DURING NEURONAL DEVELOPM
神经元发育过程中营养分子的机制
基本信息
- 批准号:2416286
- 负责人:
- 金额:$ 27.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The long term goal of this study is to understand the molecular and
cellular mechanisms of target- neuron interactions during development. We
will accomplish this goal by applying a variety of methods for
manipulating gene and protein expression during chicken embryo development
in vivo. These studies are expected to advance the understanding of the
development and maintenance of the nervous system, providing insights into
the processes of neural maintenance and neurodegenerative disease. Our
studies will use the avian ciliary ganglion (CG) because of its simple
neuronal composition, the accessibility of the neurons and their targets
throughout development, and the coincidence of synapse formation, cell
death, and transmitter expression within a well-defined window of
development. The CG contains two populations of neurons: ciliary neurons
that innervate iris and ciliary body and choroid neurons that innervate
arterial smooth muscle in the choroid layer of the eye. We have identified
three molecules by their actions on CG neurons in cell culture: growth
promoting activity (GPA), which supports neuronal survival; activin A,
which induces the expression of somatostatin; and follistatin, an
inhibitor of activin. Our working model is that availability and levels of
these three target-derived molecules regulate survival and neuropeptide
phenotype of CG neurons. We will determine the validity of this model by
testing the following hypotheses: l). Cell death in the CG during
development is controlled by GPA expressed in the iris, ciliary body, and
choroid layer; 2) Specific expression of somatostatin in choroid neurons
of the CG is induced by activin expressed in the choroid layer, whereas
follistatin blocks the effects of activin expressed in the iris/ciliary
body. The specific aims are: l) to overexpress GPA in order to determine
if CG neurons are rescued from cell death; 2) to use cell cultures of CG
target tissues as well as Co-cultures to assay the effectiveness of GPA
blocking agents; 3) to block GPA during embryonic development in vivo to
determine if CG cell death is exacerbated; 4) to identify the mechanism by
which alpha bungarotoxin increases CG neuron survival; 5) to quantify and
characterize GPA receptor and receptor associated molecules during
development; 6) to test the effectiveness of activin and follistatin
blocking agents on co-cultures of CG neurons with choroid smooth muscle
and iris/ciliary body; 7) to block to the action of activin in vivo to
determine if somatostatin expression in choroid neurons is prevented; 8)
to inject activin in the anterior chamber of the eye to induce
somatostatin in ciliary neurons; 9) to block the effects of follistatin in
the iris/ciliary body to determine if somatostatin is induced in ciliary
neurons.
这项研究的长期目标是了解分子和
发育过程中靶神经元相互作用的细胞机制。我们
将通过应用多种方法来实现这一目标
在鸡胚胎发育过程中操纵基因和蛋白质表达
体内。期望这些研究能够提高对
神经系统的开发和维护,为
神经维持和神经退行性疾病的过程。我们的
研究将使用禽睫状神经节(CG),因为它的简单
神经元组成,神经元的可及性及其靶标
在整个发育中,以及突触形成的巧合,细胞
死亡和发射器表达在明确的窗口中
发展。 CG包含两个神经元群:纤毛神经元
支配虹膜和睫状体和脉络膜神经元,这些神经元
眼睛脉络膜中的动脉平滑肌。我们已经确定了
三个分子通过对细胞培养中CG神经元的作用的作用:生长
促进活动(GPA),支持神经元生存;激活素A,
诱导生长抑素的表达;和follistatin,an
激活素抑制剂。我们的工作模型是可用性和
这三个靶点分子调节生存和神经肽
CG神经元的表型。我们将通过
测试以下假设:L)。在CG中的细胞死亡
开发由虹膜,睫状体和
脉络层; 2)脉络膜神经元中生长抑素的特异性表达
CG的诱导素在脉络膜层中表达,而
Follistatin阻断虹膜/睫状体中表达的激活素的作用
身体。具体目的是:l)过表达GPA以确定
如果CG神经元从细胞死亡中救出; 2)使用CG的细胞培养物
靶组织以及共培养以测定GPA的有效性
阻止代理; 3)在体内阻止胚胎发育期间的GPA
确定CG细胞死亡是否加剧; 4)通过
哪种αBungarotoxin会增加CG神经元存活; 5)量化和
表征GPA受体和受体相关的分子
发展; 6)测试激活素和卵泡素的有效性
用脉络膜平滑肌阻止CG神经元共培养的剂
和虹膜/睫状体; 7)阻止活化蛋白在体内的作用
确定是否预防脉络膜神经元中的生长抑素表达; 8)
在眼前室内注入激活素以诱导
睫状神经元中的生长抑素; 9)阻止Follistatin在
虹膜/睫状体,确定睫状体中是否诱导生长抑素
神经元。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Rae Nishi的其他基金
Frontiers in Stem Cells and Regeneration Course
干细胞与再生前沿课程
- 批准号:92666809266680
- 财政年份:2014
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Frontiers in Reproduction(FIR)Training Course
繁殖前沿(FIR)培训课程
- 批准号:92499589249958
- 财政年份:2014
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Gene Regulatory Networks for Development
促进发展的基因调控网络
- 批准号:89137028913702
- 财政年份:2012
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Nicotinic acetylcholine receptors and neuroblastoma
烟碱乙酰胆碱受体与神经母细胞瘤
- 批准号:82310458231045
- 财政年份:2011
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Nicotinic acetylcholine receptors and neuroblastoma
烟碱乙酰胆碱受体与神经母细胞瘤
- 批准号:83260618326061
- 财政年份:2011
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Adolescent brains, nicotine and endogenous prototoxins
青少年大脑、尼古丁和内源性原毒素
- 批准号:78146347814634
- 财政年份:2009
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Adolescent brains, nicotine and endogenous prototoxins
青少年大脑、尼古丁和内源性原毒素
- 批准号:79339947933994
- 财政年份:2009
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Nicotinic Acetylcholine Receptors in Neural Development
神经发育中的烟碱乙酰胆碱受体
- 批准号:70930717093071
- 财政年份:2005
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Nicotinic Acetylcholine Receptors in Neural Development
神经发育中的烟碱乙酰胆碱受体
- 批准号:72289397228939
- 财政年份:2005
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
相似国自然基金
反义寡核苷酸—核酸适配体嵌合体的靶向分子设计与催化降解机理研究
- 批准号:22307124
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:22207006
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
维生素E-PEG修饰自组装反义核酸药物靶向MAPK14和BChE治疗神经炎症诱发阿尔兹海默症的应用基础研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:52203187
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
持续碱基配对竞争降低反义锁核酸药物脱靶毒性的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Scatter factor induced carcinoma cell migration
散射因子诱导癌细胞迁移
- 批准号:67951376795137
- 财政年份:2003
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Scatter factor induced carcinoma cell migration
散射因子诱导癌细胞迁移
- 批准号:66811906681190
- 财政年份:2003
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Role of Frzb-1 in Chick Melanogenesis
Frzb-1 在鸡黑色素生成中的作用
- 批准号:64583216458321
- 财政年份:2002
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
Novel function for VEGF in breast carcinoma survival
VEGF 在乳腺癌生存中的新功能
- 批准号:71151407115140
- 财政年份:2002
- 资助金额:$ 27.35万$ 27.35万
- 项目类别:
The Role of Babesia bovis MSA-1 in Erythrocyte Invasion
牛巴贝虫 MSA-1 在红细胞侵袭中的作用
- 批准号:67501216750121
- 财政年份:2002
- 资助金额:$ 27.35万$ 27.35万
- 项目类别: